Connection

Perry Molinoff to Animals

This is a "connection" page, showing publications Perry Molinoff has written about Animals.
Connection Strength

0.756
  1. Selective facilitation of sexual solicitation in the female rat by a melanocortin receptor agonist. Proc Natl Acad Sci U S A. 2004 Jul 06; 101(27):10201-4.
    View in: PubMed
    Score: 0.017
  2. PT-141: a melanocortin agonist for the treatment of sexual dysfunction. Ann N Y Acad Sci. 2003 Jun; 994:96-102.
    View in: PubMed
    Score: 0.016
  3. Regulation of levels of 5-HT2A receptor mRNA. Ann N Y Acad Sci. 1998 Dec 15; 861:128-35.
    View in: PubMed
    Score: 0.012
  4. Characterization of 5-HT- and ionomycin-stimulated changes in levels of intracellular calcium and PI hydrolysis in P11 cells. Ann N Y Acad Sci. 1998 Dec 15; 861:240-1.
    View in: PubMed
    Score: 0.012
  5. Use of subunit-specific antisense oligodeoxynucleotides to define developmental changes in the properties of N-methyl-D-aspartate receptors. Mol Pharmacol. 1996 Sep; 50(3):631-8.
    View in: PubMed
    Score: 0.010
  6. Differential coupling of rat D2 dopamine receptor isoforms expressed in Spodoptera frugiperda insect cells. J Pharmacol Exp Ther. 1996 Feb; 276(2):784-94.
    View in: PubMed
    Score: 0.010
  7. Regulation of 5-HT2A receptor mRNA in P11 cells. Behav Brain Res. 1996; 73(1-2):187-91.
    View in: PubMed
    Score: 0.010
  8. Expression of mRNAs encoding subunits of the NMDA receptor in developing rat brain. J Neurochem. 1995 Feb; 64(2):531-9.
    View in: PubMed
    Score: 0.009
  9. Regulation of mRNA encoding 5-HT2A receptors in P11 cells through a post-transcriptional mechanism requiring activation of protein kinase C. J Biol Chem. 1994 Dec 16; 269(50):31850-7.
    View in: PubMed
    Score: 0.009
  10. Sensitivity of the N-methyl-D-aspartate receptor to polyamines is controlled by NR2 subunits. Mol Pharmacol. 1994 May; 45(5):803-9.
    View in: PubMed
    Score: 0.009
  11. Characterization of a 5-hydroxytryptamine receptor in mouse neuroblastoma N18TG2 cells. J Pharmacol Exp Ther. 1994 Apr; 269(1):246-55.
    View in: PubMed
    Score: 0.009
  12. Characterization of [125I](R)-trans-7-hydroxy-2-[N-propyl-N-(3'-iodo-2'-propenyl)amino] tetralin binding to dopamine D3 receptors in rat olfactory tubercle. J Pharmacol Exp Ther. 1994 Feb; 268(2):935-42.
    View in: PubMed
    Score: 0.008
  13. Molecular pharmacology of NMDA receptors: modulatory role of NR2 subunits. Prog Brain Res. 1994; 100:39-45.
    View in: PubMed
    Score: 0.008
  14. Paradoxical regulation of dopamine receptors in transfected 293 cells. Mol Pharmacol. 1993 Aug; 44(2):371-9.
    View in: PubMed
    Score: 0.008
  15. Development of polyclonal anti-D2 dopamine receptor antibodies to fusion proteins: inhibition of D2 receptor-G protein interaction. J Neurochem. 1993 Jun; 60(6):2181-91.
    View in: PubMed
    Score: 0.008
  16. Effects of agonists, partial agonists, and antagonists on the regulation of 5-hydroxytryptamine2 receptors in P11 cells. Mol Pharmacol. 1993 May; 43(5):726-33.
    View in: PubMed
    Score: 0.008
  17. Development of polyclonal anti-D2 dopamine receptor antibodies using sequence-specific peptides. Mol Pharmacol. 1993 May; 43(5):666-76.
    View in: PubMed
    Score: 0.008
  18. Expression and characterization of the rat D3 dopamine receptor: pharmacologic properties and development of antibodies. J Pharmacol Exp Ther. 1993 Feb; 264(2):1002-11.
    View in: PubMed
    Score: 0.008
  19. Developmental switch in the expression of NMDA receptors occurs in vivo and in vitro. Neuron. 1993 Feb; 10(2):267-78.
    View in: PubMed
    Score: 0.008
  20. Regulation of the 5-hydroxytryptamine1B receptor in opossum kidney cells after exposure to agonists. Mol Pharmacol. 1992 Sep; 42(3):464-70.
    View in: PubMed
    Score: 0.008
  21. An antagonist/partial agonist at the polyamine recognition site of the N-methyl-D-aspartate receptor that alters the properties of the glutamate recognition site. J Pharmacol Exp Ther. 1992 Aug; 262(2):539-44.
    View in: PubMed
    Score: 0.008
  22. Comparison of the expression, transcription and genomic organization of D2 dopamine receptors in outbred and inbred strains of rat. Brain Res. 1992 Jul 03; 584(1-2):45-54.
    View in: PubMed
    Score: 0.008
  23. Up-regulation of N-methyl-D-aspartate receptors on cultured cortical neurons after exposure to antagonists. Mol Pharmacol. 1992 Jul; 42(1):147-51.
    View in: PubMed
    Score: 0.008
  24. Identification of ascorbate as an endogenous substance that irreversibly inhibits binding of dihydropyridine calcium channel blockers. J Neurochem. 1992 Apr; 58(4):1300-7.
    View in: PubMed
    Score: 0.007
  25. Effects of mono-, di-, and triamines on the N-methyl-D-aspartate receptor complex: a model of the polyamine recognition site. Mol Pharmacol. 1992 Apr; 41(4):785-92.
    View in: PubMed
    Score: 0.007
  26. Down-regulation of beta-adrenergic receptors by pindolol in Gs alpha-transfected S49 cyc- murine lymphoma cells. J Neurochem. 1992 Mar; 58(3):1093-1103.
    View in: PubMed
    Score: 0.007
  27. Quantitation of isotypes of D2 receptors using solution hybridization. Neurochem Int. 1992 Mar; 20 Suppl:189S-195S.
    View in: PubMed
    Score: 0.007
  28. Beta-adrenergic receptor-G protein-adenylate cyclase complex in experimental canine congestive heart failure produced by rapid ventricular pacing. Circ Res. 1991 Dec; 69(6):1546-56.
    View in: PubMed
    Score: 0.007
  29. Developmental changes in the sensitivity of the N-methyl-D-aspartate receptor to polyamines. Mol Pharmacol. 1991 Nov; 40(5):774-82.
    View in: PubMed
    Score: 0.007
  30. Inhibition of binding of [3H]PN200-110 to membranes from rat brain and heart by ascorbate is mediated by lipid peroxidation. J Pharmacol Exp Ther. 1991 Oct; 259(1):337-44.
    View in: PubMed
    Score: 0.007
  31. Polyamines modulate the binding of [3H]MK-801 to the solubilized N-methyl-D-aspartate receptor. J Neurochem. 1991 Sep; 57(3):811-8.
    View in: PubMed
    Score: 0.007
  32. Regulation of dopamine D2 receptors in a novel cell line (SUP1). Mol Pharmacol. 1991 Apr; 39(4):531-9.
    View in: PubMed
    Score: 0.007
  33. Modulation of the NMDA receptor by polyamines. Life Sci. 1991; 48(6):469-98.
    View in: PubMed
    Score: 0.007
  34. Synthesis and applications of an aldehyde-containing analogue of SCH-23390. Bioconjug Chem. 1990 Nov-Dec; 1(6):394-9.
    View in: PubMed
    Score: 0.007
  35. Characterization of polyamines having agonist, antagonist, and inverse agonist effects at the polyamine recognition site of the NMDA receptor. Neuron. 1990 Aug; 5(2):199-208.
    View in: PubMed
    Score: 0.007
  36. Antibodies with high affinity for spiroperidol--II. Cross reactivity with iodobenzamide and domperidone. Mol Immunol. 1990 Jul; 27(7):667-77.
    View in: PubMed
    Score: 0.007
  37. Receptors for monoamines on cultured cells. Am J Hypertens. 1990 Jun; 3(6 Pt 2):43S-46S.
    View in: PubMed
    Score: 0.007
  38. Serotonin-2 receptors coupled to phosphoinositide hydrolysis in a clonal cell line. Mol Pharmacol. 1990 May; 37(5):622-30.
    View in: PubMed
    Score: 0.006
  39. Effects of polyamines on the binding of [3H]MK-801 to the N-methyl-D-aspartate receptor: pharmacological evidence for the existence of a polyamine recognition site. Mol Pharmacol. 1989 Oct; 36(4):575-81.
    View in: PubMed
    Score: 0.006
  40. Subtype-selective immunoprecipitation of the beta 2-adrenergic receptor. J Neurochem. 1989 Aug; 53(2):362-9.
    View in: PubMed
    Score: 0.006
  41. Characterization of membrane-bound and soluble D2 receptors in canine caudate using [125I]IBZM. J Pharmacol Exp Ther. 1989 Jul; 250(1):110-6.
    View in: PubMed
    Score: 0.006
  42. Regulation of subtypes of beta-adrenergic receptors in rat brain following treatment with 6-hydroxydopamine. J Neurosci. 1989 Jul; 9(7):2297-305.
    View in: PubMed
    Score: 0.006
  43. Effects of chronic treatment with selective and nonselective antagonists on the subtypes of dopamine receptors. Synapse. 1989; 3(1):74-82.
    View in: PubMed
    Score: 0.006
  44. Interaction of beta-adrenergic receptors with the inhibitory guanine nucleotide-binding protein of adenylate cyclase in membranes prepared from cyc- S49 lymphoma cells. Biochem Pharmacol. 1988 Nov 15; 37(22):4289-97.
    View in: PubMed
    Score: 0.006
  45. [3H]SCH 23390 labels both dopamine-1 and 5-hydroxytryptamine1c receptors in the choroid plexus. J Pharmacol Exp Ther. 1988 Oct; 247(1):343-8.
    View in: PubMed
    Score: 0.006
  46. Effects of ethanol in vitro on the beta adrenergic receptor-coupled adenylate cyclase system. J Pharmacol Exp Ther. 1988 Sep; 246(3):1040-7.
    View in: PubMed
    Score: 0.006
  47. Effects of chronic exposure to ethanol on the physical and functional properties of the plasma membrane of S49 lymphoma cells. Biochemistry. 1988 Jul 26; 27(15):5700-7.
    View in: PubMed
    Score: 0.006
  48. Monoclonal antibodies with high affinity for spiroperidol. J Neurochem. 1988 Apr; 50(4):1253-62.
    View in: PubMed
    Score: 0.006
  49. Effects of chronic administration of neuroleptic and anticholinergic agents on densities of D2 dopamine and muscarinic cholinergic receptors in rat striatum. J Pharmacol Exp Ther. 1988 Mar; 244(3):987-93.
    View in: PubMed
    Score: 0.006
  50. Endogenous modulators of binding of [3H]nitrendipine in extracts of rat brain. J Pharmacol Exp Ther. 1988 Mar; 244(3):971-6.
    View in: PubMed
    Score: 0.006
  51. Characterization of binding sites for [3H]spiroperidol. Biochem Pharmacol. 1987 Oct 01; 36(19):3255-64.
    View in: PubMed
    Score: 0.005
  52. Characterization of D-2 dopamine receptors in a tumor of the rat anterior pituitary gland. J Pharmacol Exp Ther. 1987 Sep; 242(3):950-6.
    View in: PubMed
    Score: 0.005
  53. Interactions of beta-adrenergic receptors with a membrane protein other than the stimulatory guanine nucleotide-binding protein. Biochem Pharmacol. 1987 Jul 15; 36(14):2263-9.
    View in: PubMed
    Score: 0.005
  54. Down regulation of beta adrenergic receptors in S49 lymphoma cells induced by atypical agonists. J Pharmacol Exp Ther. 1986 Dec; 239(3):654-60.
    View in: PubMed
    Score: 0.005
  55. Quantitative autoradiographic localization of the D1 and D2 subtypes of dopamine receptors in rat brain. J Neurosci. 1986 Nov; 6(11):3177-88.
    View in: PubMed
    Score: 0.005
  56. Kinetic analysis of the interactions of agonists and antagonists with beta adrenergic receptors. J Pharmacol Exp Ther. 1986 Oct; 239(1):136-43.
    View in: PubMed
    Score: 0.005
  57. A quantitative method of analyzing the interaction of slightly selective radioligands with multiple receptor subtypes. Mol Pharmacol. 1986 Oct; 30(4):329-37.
    View in: PubMed
    Score: 0.005
  58. Effects of pindolol and propranolol on beta adrenergic receptors on human lymphocytes. J Pharmacol Exp Ther. 1986 Oct; 239(1):117-23.
    View in: PubMed
    Score: 0.005
  59. Beta adrenergic receptor subtypes in the atria: evidence for close coupling of beta-1 and beta-2 adrenergic receptors to adenylate cyclase. J Pharmacol Exp Ther. 1986 Sep; 238(3):886-92.
    View in: PubMed
    Score: 0.005
  60. Turnover of beta 1- and beta 2-adrenergic receptors after down-regulation or irreversible blockade. Mol Pharmacol. 1986 Aug; 30(2):104-11.
    View in: PubMed
    Score: 0.005
  61. Relationship between ethanol-induced alterations in fluorescence anisotropy and adenylate cyclase activity. Biochem Pharmacol. 1986 Jul 15; 35(14):2331-5.
    View in: PubMed
    Score: 0.005
  62. Quantitative analysis of the selectivity of radioligands for subtypes of beta adrenergic receptors. J Pharmacol Exp Ther. 1986 Jul; 238(1):46-53.
    View in: PubMed
    Score: 0.005
  63. Effects of chronic administration of agonists and antagonists on the density of beta-adrenergic receptors. Am J Cardiol. 1986 Apr 25; 57(12):17F-22F.
    View in: PubMed
    Score: 0.005
  64. Thermodynamic properties of agonist interactions with the beta adrenergic receptor-coupled adenylate cyclase system. I. High- and low-affinity states of agonist binding to membrane-bound beta adrenergic receptors. J Pharmacol Exp Ther. 1986 Apr; 237(1):154-64.
    View in: PubMed
    Score: 0.005
  65. Thermodynamic properties of agonist interactions with the beta adrenergic receptor-coupled adenylate cyclase system. II. Agonist binding to soluble beta adrenergic receptors. J Pharmacol Exp Ther. 1986 Apr; 237(1):165-72.
    View in: PubMed
    Score: 0.005
  66. Adenylate kinase increases adenylate cyclase activity in membranes from rat lung. J Cyclic Nucleotide Protein Phosphor Res. 1986; 11(1):63-73.
    View in: PubMed
    Score: 0.005
  67. Selective regulation of beta-1 and beta-2 adrenergic receptors by atypical agonists. J Pharmacol Exp Ther. 1985 Dec; 235(3):657-64.
    View in: PubMed
    Score: 0.005
  68. Properties of beta-adrenergic receptors of cultured mammalian cells. Interaction of receptors with a guanine nucleotide-binding protein in membranes prepared from L6 myoblasts and from wild-type and cyc- S49 lymphoma cells. J Biol Chem. 1985 Nov 25; 260(27):14580-8.
    View in: PubMed
    Score: 0.005
  69. Beta 2-adrenergic receptors contribute to catecholamine-stimulated shortening of action potential duration in dog atrial muscle. Proc Natl Acad Sci U S A. 1985 Jul; 82(13):4521-5.
    View in: PubMed
    Score: 0.005
  70. Interactions of agonists with beta-adrenergic receptors on S49 lymphoma cells. Adv Cyclic Nucleotide Protein Phosphorylation Res. 1985; 19:13-27.
    View in: PubMed
    Score: 0.004
  71. Differential effects of cytosolic modulators of fluoride-stimulated adenylate cyclase activity in striatum and cerebral cortex. Alcohol Drug Res. 1985-1986; 6(6):379-86.
    View in: PubMed
    Score: 0.004
  72. Assay of dopamine receptors with [alpha-3H]flupenthixol. J Pharmacol Exp Ther. 1985 Jan; 232(1):57-61.
    View in: PubMed
    Score: 0.004
  73. Desensitization of beta-adrenergic receptor-coupled adenylate cyclase activity. Differences following exposure of cells to two full agonists. Biochem Pharmacol. 1984 Nov 15; 33(22):3579-84.
    View in: PubMed
    Score: 0.004
  74. Relationship between intrinsic activities of agonists in normal and desensitized tissue and agonist-induced loss of beta adrenergic receptors. J Pharmacol Exp Ther. 1984 Sep; 230(3):614-8.
    View in: PubMed
    Score: 0.004
  75. In vitro interactions of agonists and antagonists with beta-adrenergic receptors. Biochem Pharmacol. 1984 Mar 15; 33(6):869-75.
    View in: PubMed
    Score: 0.004
  76. Agonist-induced changes in the properties of beta-adrenergic receptors on intact S49 lymphoma cells. Time-dependent changes in the affinity of the receptor for agonists. Mol Pharmacol. 1984 Mar; 25(2):209-18.
    View in: PubMed
    Score: 0.004
  77. A comprehensive method for the quantitative determination of dopamine receptor subtypes. Ann N Y Acad Sci. 1984; 430:77-90.
    View in: PubMed
    Score: 0.004
  78. Multiple sites of action of ethanol on adenylate cyclase. J Pharmacol Exp Ther. 1983 Dec; 227(3):551-6.
    View in: PubMed
    Score: 0.004
  79. Interactions of full and partial agonists with beta-adrenergic receptors on intact L6 muscle cells. Mol Pharmacol. 1983 Nov; 24(3):398-408.
    View in: PubMed
    Score: 0.004
  80. Diminished catalepsy and dopamine metabolism distinguish aripiprazole from haloperidol or risperidone. Eur J Pharmacol. 2003 Jul 04; 472(1-2):89-97.
    View in: PubMed
    Score: 0.004
  81. Thermodynamic differences between agonist and antagonist interactions with binding sites for [3H]spiroperidol in rat striatum. Mol Pharmacol. 1983 Mar; 23(2):303-9.
    View in: PubMed
    Score: 0.004
  82. Effects of drugs on beta-adrenergic receptors on human lymphocytes. J Cardiovasc Pharmacol. 1983; 5 Suppl 1:S63-7.
    View in: PubMed
    Score: 0.004
  83. beta-Adrenergic receptor subtypes in rat brain. Adv Biochem Psychopharmacol. 1983; 36:73-81.
    View in: PubMed
    Score: 0.004
  84. Selective changes in the density of beta 1-adrenergic receptors in rat striatum following chronic drug treatment and adrenalectomy. Brain Res. 1982 Dec 09; 252(2):309-14.
    View in: PubMed
    Score: 0.004
  85. Quantitative determination of dopamine receptor subtypes not linked to activation of adenylate cyclase in rat striatum. Proc Natl Acad Sci U S A. 1982 Dec; 79(23):7561-5.
    View in: PubMed
    Score: 0.004
  86. Changes in the density of beta adrenergic receptors in rat lymphocytes, heart and lung after chronic treatment with propranolol. J Pharmacol Exp Ther. 1982 May; 221(2):439-43.
    View in: PubMed
    Score: 0.004
  87. Selective increases in the density of cerebellar beta-1-adrenergic receptors. Brain Res. 1982 Feb 25; 234(2):474-9.
    View in: PubMed
    Score: 0.004
  88. Effects of magnesium and N-ethylmaleimide on the binding of 3H-hydroxybenzylisoproterenol to beta-adrenergic receptors. J Biol Chem. 1982 Jan 25; 257(2):804-10.
    View in: PubMed
    Score: 0.004
  89. Quantitative analysis of drug-receptor interactions: II. Determination of the properties of receptor subtypes. Life Sci. 1981 Aug 03; 29(5):427-43.
    View in: PubMed
    Score: 0.004
  90. Quantitative analysis of drug-receptor interactions: I. Determination of kinetic and equilibrium properties. Life Sci. 1981 Jul 27; 29(4):313-30.
    View in: PubMed
    Score: 0.004
  91. Dopamine receptor changes following destruction of the nigrostriatal pathway: lack of a relationship to rotational behavior. Brain Res. 1981 May 04; 211(2):315-27.
    View in: PubMed
    Score: 0.003
  92. Binding of [3H]amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene to rat striatal membranes. Effects of purine nucleotides and ultraviolet irradiation. Mol Pharmacol. 1981 May; 19(3):372-8.
    View in: PubMed
    Score: 0.003
  93. Targeting acute ischemic stroke with a calcium-sensitive opener of maxi-K potassium channels. Nat Med. 2001 Apr; 7(4):471-7.
    View in: PubMed
    Score: 0.003
  94. Selective survival of beta 1-adenergic receptors in rat cerebellum following neonatal x-irradiation. Brain Res. 1981 Mar 23; 209(1):25-34.
    View in: PubMed
    Score: 0.003
  95. Effects of hypoxia on density of beta-adrenergic receptors. J Appl Physiol Respir Environ Exerc Physiol. 1981 Feb; 50(2):363-6.
    View in: PubMed
    Score: 0.003
  96. Beta-adrenergic receptor subtypes: properties, distribution, and regulation. Annu Rev Neurosci. 1981; 4:419-61.
    View in: PubMed
    Score: 0.003
  97. Interactions of agonists and antagonists with beta-adrenergic receptors. Adv Cyclic Nucleotide Res. 1981; 14:51-67.
    View in: PubMed
    Score: 0.003
  98. Activation of adenylate cyclase by ethanol in mouse striatal tissue. J Pharmacol Exp Ther. 1981 Jan; 216(1):129-34.
    View in: PubMed
    Score: 0.003
  99. Thermodynamics of agonist and antagonist interactions with mammalian beta-adrenergic receptors. Mol Pharmacol. 1980 Nov; 18(3):341-7.
    View in: PubMed
    Score: 0.003
  100. Alterations in beta 1- and beta 2-adrenergic receptor density in the cerebellum of aging rats. J Neurochem. 1980 Jul; 35(1):273-5.
    View in: PubMed
    Score: 0.003
  101. Effects of ethanol administration and withdrawal on neurotransmitter receptor systems in C57 mice. J Pharmacol Exp Ther. 1980 Jun; 213(3):491-6.
    View in: PubMed
    Score: 0.003
  102. Classification and quantitation of beta-adrenergic receptor subtypes. Biochem Pharmacol. 1980 May 15; 29(10):1317-23.
    View in: PubMed
    Score: 0.003
  103. Ontogeny of beta 1- and beta 2-adrenergic receptors in rat cerebellum and cerebral cortex. Brain Res. 1980 Apr 28; 188(2):357-68.
    View in: PubMed
    Score: 0.003
  104. Brain neurotransmitter receptor systems in mice genetically selected for differences in sensitivity to ethanol. Pharmacol Biochem Behav. 1980 Apr; 12(4):509-13.
    View in: PubMed
    Score: 0.003
  105. Differential distribution of beta-1 and beta-2 adrenergic receptors in cat and guinea-pig heart. J Pharmacol Exp Ther. 1980 Mar; 212(3):503-8.
    View in: PubMed
    Score: 0.003
  106. Brain neurotransmitter receptor systems in alcohol treated mice and in mice genetically selected for differences in sensitivity to alcohol. Adv Exp Med Biol. 1980; 132:787-95.
    View in: PubMed
    Score: 0.003
  107. Characterization of radiolabeled agonist binding to beta-adrenergic receptors in mammalian tissues. J Cyclic Nucleotide Res. 1980; 6(3):217-30.
    View in: PubMed
    Score: 0.003
  108. A comparison of the beta-adrenergic receptor of the turkey erythrocyte with mammalian beta1 and beta2 receptors. Mol Pharmacol. 1980 Jan; 17(1):1-7.
    View in: PubMed
    Score: 0.003
  109. Interactions of agonists and antagonists with beta-adrenergic receptors on intact L6 muscle cells. J Cyclic Nucleotide Res. 1980; 6(6):421-35.
    View in: PubMed
    Score: 0.003
  110. Persistence of beta-adrenergic receptors in rat striatum following kainic acid administration. Brain Res. 1979 Dec 14; 178(2-3):589-95.
    View in: PubMed
    Score: 0.003
  111. Comparison of beta adrenergic receptor subtypes in mammalian tissues. J Pharmacol Exp Ther. 1979 Dec; 211(3):502-8.
    View in: PubMed
    Score: 0.003
  112. Increased membrane acyl chain ordering activates adenylate cyclase. J Biol Chem. 1979 Sep 25; 254(18):9135-41.
    View in: PubMed
    Score: 0.003
  113. Fundamental difference between the molecular interactions of agonists and antagonists with the beta-adrenergic receptor. Nature. 1979 Sep 13; 281(5727):114-7.
    View in: PubMed
    Score: 0.003
  114. Agonist-induced changes in beta adrenergic receptor density and receptor-mediated responsiveness in slices of rat cerebral cortex. J Pharmacol Exp Ther. 1979 Sep; 210(3):433-9.
    View in: PubMed
    Score: 0.003
  115. Multiple effects of guanosine triphosphate on beta adrenergic receptors and adenylate cyclase activity in rat heart, lung and brain. J Pharmacol Exp Ther. 1979 Aug; 210(2):215-21.
    View in: PubMed
    Score: 0.003
  116. The pharmacological specificity of beta-1 and beta-2 adrenergic receptors in rat heart and lung in vitro. Mol Pharmacol. 1979 Jul; 16(1):21-33.
    View in: PubMed
    Score: 0.003
  117. Simultaneous determination of beta-1 and beta-2-adrenergic receptors in tissues containing both receptor subtypes. Mol Pharmacol. 1979 Jul; 16(1):34-46.
    View in: PubMed
    Score: 0.003
  118. Regional distribution of beta 1- and beta 2-adrenoceptors in the right atrium and left ventricle of the cat and guinea pig heart [proceedings]. Br J Pharmacol. 1979 Jul; 66(3):505P.
    View in: PubMed
    Score: 0.003
  119. beta1- and beta2-Adrenergic receptors in rat cerebral cortex are independently regulated. Science. 1979 May 25; 204(4395):866-8.
    View in: PubMed
    Score: 0.003
  120. Presynaptic modulation of beta adrenergic receptors in rat cerebral cortex after treatment with antidepressants. J Pharmacol Exp Ther. 1978 Nov; 207(2):446-57.
    View in: PubMed
    Score: 0.003
  121. Effect of guanine nucleotides on striatal dopamine receptors. Nature. 1978 Oct 05; 275(5679):453-5.
    View in: PubMed
    Score: 0.003
  122. Adrenergic storage vesicles in rat heart: quantitation of membrane-bound and membrane-enclosed dopamine beta-hydroxylase. J Pharmacol Exp Ther. 1978 May; 205(2):357-65.
    View in: PubMed
    Score: 0.003
  123. Regulation of beta-adrenergic receptors in the cerebral cortex. Adv Cyclic Nucleotide Res. 1978; 9:465-83.
    View in: PubMed
    Score: 0.003
  124. Supersensitivity in rat cerebral cortex: pre- and postsynaptic effects of 6-hydroxydopamine at noradrenergic synapses. Mol Pharmacol. 1977 Nov; 13(6):1170-80.
    View in: PubMed
    Score: 0.003
  125. Effects of 6-hydroxydopamine on the development of the beta adrenergic receptor/adenylate cyclase system in rat cerebral cortex. J Pharmacol Exp Ther. 1977 Oct; 203(1):132-43.
    View in: PubMed
    Score: 0.003
  126. Endogenous inhibitors of dopamine beta-hydroxylase: separation of multiple forms and access to the enzyme. J Pharmacol Exp Ther. 1977 Sep; 202(3):590-600.
    View in: PubMed
    Score: 0.003
  127. 5-hydroxytryptamine1A receptor-mediated increases in receptor expression and activation of nuclear factor-kappaB in transfected Chinese hamster ovary cells. Mol Pharmacol. 1997 Aug; 52(2):221-6.
    View in: PubMed
    Score: 0.003
  128. Ontogeny of beta-adrenergic receptors in rat cerebral cortex. Brain Res. 1977 Apr 08; 125(1):99-108.
    View in: PubMed
    Score: 0.003
  129. Octopamine: normal occurrence in central and peripheral nerves of rats. Psychopharmacol Bull. 1976 Oct; 12(4):32-4.
    View in: PubMed
    Score: 0.003
  130. Differential effects of nerve impulses on adrenergic storage vesicles in rat heart. J Pharmacol Exp Ther. 1976 Jul; 198(1):112-22.
    View in: PubMed
    Score: 0.002
  131. Endogenous inhibitors of dopamine-beta- hydroxylase in rat organs. Biochem Pharmacol. 1976 May 15; 25(10):1167-74.
    View in: PubMed
    Score: 0.002
  132. Distribution and properties of adrenergic storage vesicles in nerve terminals. J Pharmacol Exp Ther. 1976 Feb; 196(2):346-59.
    View in: PubMed
    Score: 0.002
  133. Expression of the human 5-hydroxytryptamine1A receptor in Sf9 cells. Reconstitution of a coupled phenotype by co-expression of mammalian G protein subunits. J Biol Chem. 1995 Aug 04; 270(31):18691-9.
    View in: PubMed
    Score: 0.002
  134. Characterization of binding sites for [125I]R(+)trans-7-OH-PIPAT in rat brain. Naunyn Schmiedebergs Arch Pharmacol. 1994 Dec; 350(6):611-7.
    View in: PubMed
    Score: 0.002
  135. Proceedings: Dopamine-beta-hydroxylase and the regulation of the noradrenergic neuron. Psychopharmacol Bull. 1974 Jul; 10(3):24-5.
    View in: PubMed
    Score: 0.002
  136. International Union of Pharmacology nomenclature of adrenoceptors. Pharmacol Rev. 1994 Jun; 46(2):121-36.
    View in: PubMed
    Score: 0.002
  137. Expression of mRNAs encoding subunits of the N-methyl-D-aspartate receptor in cultured cortical neurons. Mol Pharmacol. 1994 May; 45(5):846-53.
    View in: PubMed
    Score: 0.002
  138. The normal occurrence of octopamine in neural tissue of the Octopus and other cephalopods. J Neurochem. 1974 Feb; 22(2):271-80.
    View in: PubMed
    Score: 0.002
  139. Dopamine-beta-hydroxylase and the regulation of the noradrenergic neuron. Adv Biochem Psychopharmacol. 1974; 12(0):95-104.
    View in: PubMed
    Score: 0.002
  140. Characterization of a mouse beta 1-adrenergic receptor genomic clone. DNA Cell Biol. 1993 Jul-Aug; 12(6):537-47.
    View in: PubMed
    Score: 0.002
  141. Cholinergic receptors in Torpedo. Neurosci Res Program Bull. 1973 Jun; 11(3):253-7.
    View in: PubMed
    Score: 0.002
  142. Induction of dopamine- -hydroxylase and tyrosine hydroxylase in rat hearts and sympathetic ganglia. J Pharmacol Exp Ther. 1972 Jul; 182(1):116-29.
    View in: PubMed
    Score: 0.002
  143. Subtypes of serotonin receptors and anxiolytic drugs: model systems for the study of 5-HT receptors. Clin Neuropharmacol. 1992; 15 Suppl 1 Pt A:531A-532A.
    View in: PubMed
    Score: 0.002
  144. Distribution and turnover of octopamine in tissues. J Neurochem. 1972 Jan; 19(1):157-63.
    View in: PubMed
    Score: 0.002
  145. Isolation of the cholinergic receptor protein of Torpedo electric tissue. Adv Biochem Psychopharmacol. 1972; 6:111-34.
    View in: PubMed
    Score: 0.002
  146. Brain dopamine- -hydroxylase: regional distribution and effects of lesions and 6-hydroxy-dopamine on activity. J Neurochem. 1972 Jan; 19(1):195-204.
    View in: PubMed
    Score: 0.002
  147. Heterogeneous distribution of dopamine D2 receptor mRNA in the rat striatum: a quantitative analysis with in situ hybridization histochemistry. Anat Rec. 1991 Dec; 231(4):548-58.
    View in: PubMed
    Score: 0.002
  148. Distribution of octopamine in nervous tissues of Octopus vulgaris. Br J Pharmacol. 1971 Oct; 43(2):438P-439P.
    View in: PubMed
    Score: 0.002
  149. Effects of 6-hydroxydopamine on the activity of tyrosine hydroxylase and dopamine- -hydroxylase in sympathetic ganglia of the rat. J Pharmacol Exp Ther. 1971 Sep; 178(3):417-24.
    View in: PubMed
    Score: 0.002
  150. A sensitive enzymatic assay for dopamine- -hydroxylase. J Pharmacol Exp Ther. 1971 Sep; 178(3):425-31.
    View in: PubMed
    Score: 0.002
  151. Trans-synaptic induction of dopamine (3,4-dihydroxyphenethylamine) -hydroxylase in adrenergic tissues of the rat. Biochem J. 1971 Jul; 123(4):32P-33P.
    View in: PubMed
    Score: 0.002
  152. Ontogeny of dopamine D1 and D2 receptor subtypes in rat basal ganglia: a quantitative autoradiographic study. Brain Res Dev Brain Res. 1991 Jun 21; 60(2):161-77.
    View in: PubMed
    Score: 0.002
  153. Biochemistry of catecholamines. Annu Rev Biochem. 1971; 40:465-500.
    View in: PubMed
    Score: 0.002
  154. Neurally mediated increase in dopamine-beta-hydroxylase activity. Proc Natl Acad Sci U S A. 1970 Jun; 66(2):453-8.
    View in: PubMed
    Score: 0.002
  155. An enzymatic assay for octopamine and other beta-hydroxylated phenylethylamines. J Pharmacol Exp Ther. 1969 Dec; 170(2):253-61.
    View in: PubMed
    Score: 0.002
  156. Skeletal muscle beta-receptors and isoproterenol-stimulated vasodilation in canine heart failure. J Appl Physiol (1985). 1989 Nov; 67(5):2026-31.
    View in: PubMed
    Score: 0.002
  157. Octopamine: normal occurrence in sympathetic nerves of rats. Science. 1969 Apr 25; 164(3878):428-9.
    View in: PubMed
    Score: 0.002
  158. Comparison of 125I-SCH 23982 and [3H]SCH 23390 as ligands for the D-1 dopamine receptor. J Neurochem. 1988 Aug; 51(2):391-7.
    View in: PubMed
    Score: 0.001
  159. The metabolism of gamma-aminobutyric acid (GABA) in the lobster nervous system--glutamic decarboxylase. J Neurochem. 1968 May; 15(5):391-409.
    View in: PubMed
    Score: 0.001
  160. Genetic influence on the regulation of beta adrenergic receptors in mice. J Pharmacol Exp Ther. 1986 Jan; 236(1):24-9.
    View in: PubMed
    Score: 0.001
  161. Effects of isoproterenol on the development of beta-adrenergic receptors in brain cell aggregates. Brain Res. 1981 Feb 23; 207(1):174-7.
    View in: PubMed
    Score: 0.001
  162. Effect of central catecholamine depletion on the osmotic and nonosmotic stimulation of vasopressin (antidiuretic hormone) in the rat. J Clin Invest. 1979 Dec; 64(6):1599-607.
    View in: PubMed
    Score: 0.001
  163. The release of endogenous norepinephrine and dopamine from cerebral cortex by amphetamine. J Pharmacol Exp Ther. 1977 Sep; 202(3):544-57.
    View in: PubMed
    Score: 0.001
  164. Octopamine in the lobster nervous system. Nat New Biol. 1972 Mar 15; 236(63):61-3.
    View in: PubMed
    Score: 0.000
  165. Induction of dopamine- -hydroxylase in rat superior cervical ganglia in organ culture. J Neurochem. 1972 Mar; 19(3):919-21.
    View in: PubMed
    Score: 0.000
  166. Electrophoretic properties of dopamine -hydroxylase in several tissues from three species. Mol Pharmacol. 1972 Jan; 8(1):50-8.
    View in: PubMed
    Score: 0.000
  167. Isolation of the cholinergic receptor protein of Torpedo electric tissue. Nature. 1971 Feb 19; 229(5286):554-7.
    View in: PubMed
    Score: 0.000
  168. A comparison of the enzymes and substrates of gamma-aminobutyric acid metabolism in lobster excitatory and inhibitory axons. Proc Natl Acad Sci U S A. 1965 Sep; 54(3):778-82.
    View in: PubMed
    Score: 0.000
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.